Minireviews
Copyright ©The Author(s) 2018.
World J Transplant. Jun 28, 2018; 8(3): 68-74
Published online Jun 28, 2018. doi: 10.5500/wjt.v8.i3.68
Table 1 Vaccination in end stage renal disease and pre-transplant
VaccineLive/inactivatedComments
Hepatitis BInactivatedHigher concentration in 3-4 divided doses Check seroconversion after 6-12 wk Repeat dosing if HBsAb titre < 10 IU/L
PneumococcalInactivated(1) Adults (≥ 19 yr), previously unvaccinated; PCV-13 followed 8 wk later by PPSV-23 (2) Previously vaccinated; Single dose of PCV-13, one year after the last PPSV-23
HPVInactivatedAll patients aged 9-26 yr
InfluenzaLive (LAV)Contra-indicated
Inactivated (TIV)Recommended annually
MMR RubellaLiveMandatory for all paediatric patients; 2 doses given 4 wk apart Single dose booster for all sero-negative adult patients For all seronegative female patients of child-bearing age
VaricellaLive attenuatedFor all paediatric and adolescent patients, completed 6 wk before transplant
HZVLiveRecommended for all elderly (> 60 yr) patients Optional for those 50-60 yr with a history of varicella or zoster No evidence of benefit in those < 50 yr
DTP Td/ TdapInactivated InactivatedFor all paediatric patients Td; Formerly (before 2005) recommended to all adult patients as a booster Tdap to all as a one-time dose followed by Td booster every 10 yr
BCGLiveRoutine neonatal vaccination done in Asia, Eastern Europe, Middle East, Africa and South America Elsewhere, recommended children < 5 yr deemed to be at high risk (see text)